Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT05758688

Whole Pelvis Proton Radiation for Gynecologic Cancer

Conditions: Cervical Cancer, Uterine Cancer

Sex: Female

Ages: 18 Years – N/A

Phase: NA

Enrollment: 25

Sponsor: University of Pennsylvania

Summary

This is a single institution, multi-center, Phase II, single-arm study, using Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT) in the post-surgical, adjuvant setting for definitive treatment of gynecologic cancers. The purpose of this study is to estimate rate of acute clinician-reported gastrointestinal (GI) toxicity using WP PBS PRT in the definitive treatment of gynecologic cancers in the post-surgical, adjuvant setting.

Eligibility Criteria

Inclusion Criteria:Histologically confirmed cervical or endometrial cancerIndication for adjuvant whole pelvic radiation therapy, with or without systemic therapyAge of 18 years or olderWritten informed consentECOG of 0-2Exclusion Criteria:Prior course of pelvic radiationMetastatic disease outside of the pelvisActive inflammatory bowel diseaseIncapacity to provide informed consent

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05758688). StuddyBuddy aggregates publicly available trial information.